A Delaware judge tossed a lawsuit by Chemours shareholders around the company’s financial health and liabilities when it was spun off from a predecessor of DuPont, according to an article from Bloomberg Law. The shareholders allege they were misled by Chemours directors about environmental liabilities tied to the PFAS class of chemicals.
Earlier this year, Chemours agreed to a $4 billion settlement with DuPont and Corteva to cover liabilities associated with “forever chemicals,” according to the article. Chemours investors allege the company was “crippled from the start” and that the directors covered up the situation through stock buybacks and dividends.
Read the entire article here.
